She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Oprah Winfrey has been slammed for her controversial comments about 'thin people' while discussing her use of weight loss ...

In a crowded market of diet pills, detox teas, and fleeting fads, FitSpresso emerges with actual peer-reviewed research ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...

The outlook cut comes as Eli Lilly competes with Novo Nordisk and other, smaller rivals for share of the exploding weight loss and diabetes drug market. Eli Lilly is developing an obesity pill ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13. The company is preparing to release key late ...

However, what if we change our mindset from taking on the next extreme weight loss routine and actually made realistic changes instead? A podcast host has done just that as she shared her ...

Separately, Eli Lilly said that it expects its new weight loss pill to be approved by U.S. regulators in 2026. The Indianapolis, Indiana-based company said that it will release late-stage trial ...

He drew widespread attention for his extreme lifestyle, including taking 54 pills for breakfast as part of his quest to extend his lifespan. Johnson recently voiced concerns about air pollution in ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks told Bloomberg. Eli Lilly and Novo Nordisk, which dominate the market ...